Our Research

Advance Research

Conquering and curing brain tumors – once and for all.

Thanks to the generosity of thousands across the country and around the world, National Brain Tumor Society is unrelentingly investing in best in class research positioned and poised to develop into novel and transformative treatments and ultimately, cures.

Latest research news

 

Latest Research News

Keep up with breaking advances in brain tumor research.

Research funding opportunities

 

Research Funding

Our innovative funding models are designed to support rigorous scientific investigation and drive progress toward treatments and the discovery of a cure.

From the Blog

  • January 14, 2021

    NBTS Brain Tumor Clinical Trials Report: Q4 2020

    It can be hard to keep track of new clinical trial opportunities opening across the United States, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many clinical trials still actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for […]

    The post Read More

  • January 7, 2021

    New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial

    Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib.  “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for pati

    Read More

  • December 19, 2020

    4 Big Takeaways From the 2020 Annual Meeting of the Society for Neuro-Oncology

    A move to a virtual platform didn’t diminish the quality of the 2020 Annual Meeting of the Society for Neuro-Oncology (SNO), the yearly gathering of the world’s foremost brain tumor researchers and clinicians. As usual, the National Brain Tumor Society was a proud platinum sponsor of this important conference and deployed our own team of […]

    The post Read More

More from the blog